HySum Flexibles Global Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Wuhui Lin

Chief executive officer

CN¥912.0k

Total compensation

CEO salary percentage	n/a
CEO tenure	14yrs
CEO ownership	30.8%
Management average tenure	14.5yrs
Board average tenure	3.9yrs

Recent management updates

Recent updates

HySum Flexibles Global (SZSE:300501) Will Be Hoping To Turn Its Returns On Capital Around

Sep 30

HySum Flexibles Global (SZSE:300501) Is Paying Out A Larger Dividend Than Last Year

May 24

HySum Flexibles Global's (SZSE:300501) Problems Go Beyond Weak Profit

May 01

There's No Escaping HySum Flexibles Global, Inc.'s (SZSE:300501) Muted Earnings Despite A 26% Share Price Rise

Apr 04

CEO

Wuhui Lin (53 yo)

14yrs

Tenure

CN¥912,000

Compensation

Mr. Wuhui Lin is Chairman & GM of HySum Flexibles Global, Inc. (formerly known as Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd.), and its Director since November 25, 2010.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Wuhui Lin	Chairman & GM	no data	CN¥912.00k	30.81% CN¥ 841.9m
Hailong Ni	CFO & Financial Director	19.8yrs	CN¥394.80k	no data
Qin Huang	Chief Investment Officer	no data	CN¥366.00k	no data
Jun Li	VP & Deputy GM	14.5yrs	CN¥840.30k	no data
Ping Chen	VP & Deputy GM	12.8yrs	CN¥780.00k	no data
Jian Fu	Director of Operations	no data	no data	no data

14.5yrs

Average Tenure

53yo

Average Age

Experienced Management: 300501's management team is seasoned and experienced (14.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Wuhui Lin	Chairman & GM	14yrs	CN¥912.00k	30.81% CN¥ 841.9m
Qin Huang	Chief Investment Officer	5yrs	CN¥366.00k	no data
Xiumei Zhu	Non-Independent Director	14yrs	CN¥618.00k	17.11% CN¥ 467.7m
Kuanyun Xia	Independent Director	5yrs	CN¥60.00k	no data
Shihong Ma	Independent Director	3.9yrs	CN¥60.00k	no data
Jian Gu	Chairman of the Supervisory Board	3.9yrs	no data	no data
Linlin Wang	Independent Director	2yrs	CN¥60.00k	no data
Xin Lin	Non-Independent Director	2yrs	CN¥564.00k	no data
Yi Zhu	Non-Employee Supervisor	2yrs	no data	no data
Ruihua Shi	Staff Supervisor	no data	no data	no data

3.9yrs

Average Tenure

46.5yo

Average Age

Experienced Board: 300501's board of directors are considered experienced (3.9 years average tenure).

HySum Flexibles Global Management

Management criteria checks 4/4

Key information

Recent management updates

HySum Flexibles Global, Inc., Annual General Meeting, May 08, 2024

High number of new directors

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Board Appointments

High number of new directors

Recent updates

HySum Flexibles Global, Inc. Proposes Cash Dividend for the Third Quarter of 2024

Third quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.25 in 3Q 2023)

HySum Flexibles Global, Inc. (SZSE:300501) announces an Equity Buyback for CNY 200 million worth of its shares.

HySum Flexibles Global, Inc. to Report Q3, 2024 Results on Oct 22, 2024

Investor sentiment improves as stock rises 24%

HySum Flexibles Global (SZSE:300501) Will Be Hoping To Turn Its Returns On Capital Around

Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.081 in 2Q 2023)

HySum Flexibles Global, Inc. to Report First Half, 2024 Results on Aug 28, 2024

HySum Flexibles Global (SZSE:300501) Is Paying Out A Larger Dividend Than Last Year

Dividend increased to CN¥0.15

HySum Flexibles Global's (SZSE:300501) Problems Go Beyond Weak Profit

HySum Flexibles Global, Inc., Annual General Meeting, May 08, 2024

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.53 in FY 2022)

Investor sentiment deteriorates as stock falls 19%

There's No Escaping HySum Flexibles Global, Inc.'s (SZSE:300501) Muted Earnings Despite A 26% Share Price Rise

Investor sentiment improves as stock rises 17%

HySum Flexibles Global, Inc. to Report Q1, 2024 Results on Apr 25, 2024

HySum Flexibles Global, Inc. (SZSE:300501) announces an Equity Buyback for CNY 100 million worth of its shares.

HySum Flexibles Global, Inc. (SZSE:300501) announces an Equity Buyback for CNY 100 million worth of its shares.

Investor sentiment deteriorates as stock falls 16%

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 18, 2024

Third quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.15 in 3Q 2022)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.081 (vs CN¥0.15 in 2Q 2022)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 16, 2023

First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 1Q 2022)

Investor sentiment improves as stock rises 27%

High number of new directors

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Board Appointments

Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.16 in 2Q 2021)

Upcoming dividend of CN¥0.12 per share

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Approves Cash Dividend for the Year 2021

High number of new directors

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Announces Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.21 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.09 in 1Q 2020)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. Proposes Final Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥0.67 (vs CN¥0.44 in FY 2019)

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 16, 2021

New 90-day low: CN¥14.78

Investor sentiment deteriorated over the past week

New 90-day low: CN¥15.35

Investor sentiment deteriorated over the past week

New 90-day low: CN¥19.63

New 90-day low: CN¥20.23

Third quarter earnings released

Market bids up stock over the past week

First half earnings released

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥34.70

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age